Completed PHASE4 INTERVENTIONAL 1-arm NCT00373178

Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes

Sponsor: Aristotle University Of Thessaloniki

Interventions Anti-diabetic medications metformin rosiglitazone

Updated 5 times since 2017 Last updated: Nov 1, 2012 Started: Jan 31, 2005 Primary completion: Jan 31, 2007 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00373178, this PHASE4 trial focuses on Type 2 Diabetes Mellitus and remains completed. Sponsored by Aristotle University Of Thessaloniki, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aristotle University Of Thessaloniki
University of Athens

Data source: Aristotle University Of Thessaloniki

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Thessaloniki, Greece